Product logins

Find logins to all Clarivate products below.


Structural Heart Closure Devices – Market Insights – Asia Pacific

Although the global COVID-19 pandemic negatively impacted the Asia Pacific structural heart closure device market in 2020, strong prepandemic growth trends in the PFO and LAA segments helped to sustain positive overall procedure volume and market growth for the year, and the market has subsequently shown strong recovery. Going forward, the market will continue to expand through 2032, supported by continued robust growth in the well-established Australian market, expanding evidence demonstrating the safety and efficacy of transcatheter and epicardial structural heart closure procedures, the introduction of new devices, and growing competition from and the strong presence of domestic manufacturers offering low-cost products in the large and expanding Chinese market.

This Medtech 360 Report provides comprehensive data and analysis on the state of the structural heart closure device market in Asia Pacific from 2019 through 2032.

The Asia Pacific structural heart closure device market will be impacted by the COVID-19 pandemic in the early years of the forecast period.

How did the COVID-19 pandemic impact the global structural heart closure device, and to what extent has it recovered?

When is the structural heart closure market expected to revert to pre-pandemic growth?

The Asia Pacific market for structural heart closure devices will grow moderately through 2032.

What are upcoming developments in the structural heart closure device market?

What ongoing clinical trials will impact the structural heart closure device market?

How are clinical developments across the globe impacting the Asia Pacific structural heart closure device market?

Which new devices have been launched over the past year and are expected to launch in the Asia Pacific market?

The LAA closure device segment represents a significant market opportunity for manufacturers in the structural heart closure device space.

What strategies will MNCs adopt to compete with the domestic players in the Asia Pacific market?

Who are the new players in the LAA closure device market?

How are the domestic players able to maintain their position in the Asia Pacific market?

Table of contents


Related Medtech Insights Reports

Report
Laparoscopic Devices – Market Insights – Asia Pacific
The Asia Pacific laparoscopic device market will experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…
Report
Heart Valve Devices – Market Insights – United States
The US heart valve device market continues to be driven by the introduction of novel products and key approvals for new indications of existing products. In particular, recent approvals of…
Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Neurovascular Devices – Market Insights – Latin America
The Latin American neurovascular device market is poised to experience moderate growth through 2034. This growth will be driven by the introduction of newly developed technologies, increasing…
Report
Transcatheter Embolization and Occlusion Devices – Market Insights – Latin America
The Latin American TEO device market is poised to experience moderate growth through 2034. This growth will be driven by the introduction of newly developed technologies, increasing adoption of…